🇦🇺 Australia Country × Condition
solid tumor Clinical Trials in Australia
Active clinical trials for solid tumor with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇦🇺 Australia
Active Trials in Australia (5)
NCT06536257
Recruiting
Personalised Immunotherapy Platform
Enrollment
1,000 pts
Country
🇦🇺 Australia
Melanoma Institute Australia
View Trial → NCT05086692 Phase 1, Phase 2
Recruiting
A Beta-only IL-2 ImmunoTherapY Study
Enrollment
115 pts
Country
🇦🇺 Australia
Medicenna Therapeutics, Inc.
View Trial → NCT05269316 Phase 1, Phase 2
Recruiting
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Enrollment
61 pts
Country
🇦🇺 Australia
Impact Therapeutics, Inc.
View Trial → NCT05735080 Phase 1, Phase 2
Recruiting
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Enrollment
150 pts
Country
🇦🇺 Australia
Incyclix Bio
View Trial → NCT05919264 Phase 1, Phase 2
Recruiting
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Enrollment
595 pts
Country
🇦🇺 Australia
Parabilis Medicines, Inc.
View Trial → Frequently Asked Questions
How many solid tumor clinical trials are active in Australia?
There are currently 5 active clinical trials for solid tumor with sites in Australia, of which 5 are actively recruiting patients.
How can I join a solid tumor clinical trial in Australia?
To join a solid tumor clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are solid tumor trials in Australia?
Active solid tumor trials in Australia span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology